Compare Aksara Global Development Tbk. (GAMA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aksara Global Development Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Aksara Global Development Tbk. trades at Rp18 (market cap 180.2B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Aksara Global Development Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| GAMA | SCPI | |
|---|---|---|
Market Cap | 180.2B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aksara Global Development Tbk.
PT Gading Development Tbk (formerly PT Artha Asia Pratama) was established based on notarial deed No. 45 dated December 18, 2003 of P. Sutrisno A. Tampubolon, S.H., M.Kn., notary in Jakarta.
Read more on GAMA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
